APAF1 and hepatocellular carcinoma: Following inhibition of HDACs 1, 2, and 3 by TSA, apoptotic protease-activating factor 1 (Apaf1) was determined to become upregulated, which leads to the stimulation of mitochondrial caspase-driven apoptosis of the HLE and HLF HCC cell lines [74].